Genetron Holdings
Latest round
- Series D
Last raised
- Nov 2019
Total raised
- $133M
Investors
- 12
About Genetron Holdings
Founded in 2013 and based in Beijing, China, Genetron Holdings Limited operates as a developer of precision medical products to provide cancer patients with molecular diagnosis and therapeutics. The company's platform offers human IDH1/TERT promoter mutation detection kit, biochip reader Genetron 3D, and Genetron S5.
Who invested in Genetron Holdings
12 investors across 3 rounds
See all investors in Genetron Holdings
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Genetron Holdings
Who invested in Genetron Holdings?
Genetron Holdings has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Genetron Holdings raised?
Genetron Holdings has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Genetron Holdings last raise money?
Genetron Holdings's most recent round on record is a Series D, in Nov 2019.
What does Genetron Holdings do?
Founded in 2013 and based in Beijing, China, Genetron Holdings Limited operates as a developer of precision medical products to provide cancer patients with molecular diagnosis and therapeutics.
Where is Genetron Holdings headquartered?
Genetron Holdings is headquartered in Beijing, China.
Which VCs invest in companies like Genetron Holdings?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Genetron Holdings's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Genetron Holdings? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.